Data Collective IV GP
$79M 13F equity value
4 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Data Collective IV GP covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| EVLV | Evolv Technologies Holdings, Inc. | 4,590,000 | $27M | 33.9% |
| HQ | Horizon Quantum Holdings Ltd | 915,198 | $25M | 32.3% |
| RXRX | Recursion Pharmaceuticals, Inc. | 5,941,120 | $22M | 27.8% |
| DFTX | Definium Therapeutics, Inc. (MindMed) | 100,350 | $5M | 6.0% |
Track Data Collective IV GP's 13F portfolio: $79M in reported holdings, 4 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}